Title:
HYALURONIC ACID DERIVATIVE PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2024/019127
Kind Code:
A1
Abstract:
This hyaluronic acid derivative pharmaceutical composition comprises (A) a hyaluronic acid derivative to which a hydrophobic group is introduced, (B) an association accelerator, and (C) an active ingredient. It is preferable that the (B) association accelerator include at least four ether structures (R-O-R) and have four or more carbon atoms.
Inventors:
YABUUCHI KOHEI (JP)
NAKAI TAKASHI (JP)
NAKAI TAKASHI (JP)
Application Number:
PCT/JP2023/026679
Publication Date:
January 25, 2024
Filing Date:
July 20, 2023
Export Citation:
Assignee:
ASAHI CHEMICAL IND (JP)
International Classes:
A61K47/36; A61K9/08; A61K38/02; A61K38/12; A61K38/13; A61K45/00; A61K47/10; A61K47/22; A61K47/26; A61K47/40; A61P37/06
Foreign References:
| JP2009079043A | 2009-04-16 | |||
| JP2022044579A | 2022-03-17 | |||
| JP2001316284A | 2001-11-13 |
Attorney, Agent or Firm:
MATSUNUMA Yasushi et al. (JP)
Download PDF:
Previous Patent: FRICTION MATERIAL COMPOSITION AND FRICTION MATERIAL
Next Patent: PLANT BIOMASS SACCHARIFYING ENZYME COMPOSITION
Next Patent: PLANT BIOMASS SACCHARIFYING ENZYME COMPOSITION